2022
DOI: 10.17582/journal.pjz/20211027111027
|View full text |Cite
|
Sign up to set email alerts
|

Anti-A and Anti-B Titer Among Blood Group O Donors at a Tertiary Care Centre Lahore, Pakistan

Abstract: Authors' Contribution NS conceived the idea of study. AS and SH performed experimental work. AS wrote the manuscript. NM and LA helped in data collection and writing of the manuscript. SA proofread the article.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…Tests of prothrombin time (PT) and activated partial thromboplastin time (APTT) are major screening methods to evaluate the endogenous coagulation pathway and the anomaly in the coagulation factor II, V and X or fibrinogen (Devreese, 2021). Plasma fibrinogen, also known as the coagulation factor I, is a protein that is mainly distributed in plasma that is involved in the process of blood coagulation, and is a soluble precursor of fibrin that could be transformed into the fibrin at the last stage of coagulation (May et al, 2021;Syyam et al, 2022). Any increase in the level of fibrinogen could further elevate the risk of thromboembolism, which is frequently seen in the patients with diabetes mellitus or acute myocardial infarction.…”
Section: O N L I N E F I R S T a R T I C L Ementioning
confidence: 99%
“…Tests of prothrombin time (PT) and activated partial thromboplastin time (APTT) are major screening methods to evaluate the endogenous coagulation pathway and the anomaly in the coagulation factor II, V and X or fibrinogen (Devreese, 2021). Plasma fibrinogen, also known as the coagulation factor I, is a protein that is mainly distributed in plasma that is involved in the process of blood coagulation, and is a soluble precursor of fibrin that could be transformed into the fibrin at the last stage of coagulation (May et al, 2021;Syyam et al, 2022). Any increase in the level of fibrinogen could further elevate the risk of thromboembolism, which is frequently seen in the patients with diabetes mellitus or acute myocardial infarction.…”
Section: O N L I N E F I R S T a R T I C L Ementioning
confidence: 99%